Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals is a clinical-stage biotechnology company that uses machine learning and automation to discover and develop new drugs. Its core business model involves preclinical drug discovery and development, an activity that inherently requires animal testing to meet regulatory requirements for safety and efficacy before human trials can begin. The company's pipeline includes candidates for neurological, oncology, and rare diseases, all of which would necessitate animal studies in the research process.

While specific, publicly disclosed details on the company's animal testing protocols are limited, its operational model as a drug discovery firm places it within the pharmaceutical sector, where animal testing is a standard, integral component of the development pathway. Companies in this space, including Recursion, fund, commission, or conduct animal testing either directly or through contract research organizations (CROs) to advance therapeutic candidates toward clinical trials and regulatory approval.